[1] Fleissig A, Fallowfield LJ, Langridge CI, et al.Post-ope-rative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer[J]. Breast Cancer Res Treat,2006,95(3):279-293.
[2] Krag DN, Anderson SJ, Julian TB, et al.Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial[J]. Lancet Oncol,2010,11(10):927-933.
[3] Wei S, Bleiweiss IJ, Nagi C, et al.Characteristics of breast carcinoma cases with false-negative sentinel lymph nodes[J]. Clin Breast Cancer,2014,14(4):280-284.
[4] Kohl Schwartz AS, Leo C, Rufibach K, et al.Does increased tumor burden of sentinel nodes in breast cancer affect detection procedure?[J]. Eur J Surg Oncol,2013, 39(3):266-272.
[5] Goyal A, Douglas-Jones AG, Newcombe RG, et al.Effect of lymphatic tumor burden on sentinel lymph node biopsy in breast cancer[J]. Breast J,2005,11(3):188-194.
[6] Zhou W, Zhao Y, Pan H, et al.Great tumour burden in the axilla may influence lymphatic drainage in breast cancer patients[J]. Breast Cancer Res Treat,2016,157(3):503-510.
[7] Proulx ST, Luciani P, Christiansen A, et al.Use of a PEG-conjugated bright near-infrared dye for functional imaging of rerouting of tumor lymphatic drainage after sentinel lymph node metastasis[J]. Biomaterials,2013, 34(21):5128-5137.
[8] Leijte JA, van der Ploeg IM, Valdes Olmos RA, et al. Visualization of tumor blockage and rerouting of lymphatic drainage in penile cancer patients by use of SPECT/CT[J]. J Nucl Med,2009,50(3):364-367.
[9] Wang Y, Zhou W, Li C, et al.Variation of sentinel lymphatic channels (SLCs) and sentinel lymph nodes (SLNs) assessed by contrast-enhanced ultrasound(CEUS) in breast cancer patients[J]. World J Surg Oncol,2017,15(1):127-133.
[10] Suga K, Yuan Y, Okada M, et al.Breast sentinel lymph node mapping at CT lymphography with iopamidol: preliminary experience[J]. Radiology,2004,230(2):543-552.
[11] Galimberti V, Cole BF, Zurrida S, et al.Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial[J]. Lancet Oncol,2013,14(4):297-305.
[12] Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial[J]. JAMA,2017,318(10):918-926.
[13] Dengel LT, Van Zee KJ, King TA, et al.Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy[J]. Ann Surg Oncol,2014,21(1):22-27.
[14] Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial[J]. Lancet Oncol,2014,15(12):1303-1310.
[15] Gentilini O, Veronesi U.Staging the axilla in early breast cancer: will imaging replace surgery?[J]. JAMA Oncol,2015,1(8):1031-1032.
[16] Boughey JC, Suman VJ, Mittendorf EA, et al.Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial[J]. JAMA,2013,310(14):1455-1461.
[17] Kuehn T, Bauerfeind I, Fehm T, et al.Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study[J]. Lancet Oncol,2013,14(7):609-618.
[18] Caudle AS, Yang WT, Krishnamurthy S, et al.Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective eva-luation of clipped nodes: implementation of targeted axillary dissection[J]. J Clin Oncol,2016,34(10):1072-1078.
